AGP Executive Report
Last update: 6 hours agoHealth AI: Jersey City’s Dyania Health is teaming with NVIDIA to run clinical-reasoning AI on hospital systems, analyzing patient records without sending them outside the hospital firewall. Biotech: Plainsboro-based Novo Nordisk has filed for U.S. and European approval of etavopivat, an investigational sickle cell treatment backed by Phase 3 trial results. Radiopharma: PharmaLogic plans to acquire Lantheus’ Springfield manufacturing facility, expanding New Jersey’s role in production and development of targeted radioactive therapies. Rutgers Research: A Rutgers Health study found that a molecule made by gut bacteria repaired intestinal damage in mice, flies and human cells, pointing to a possible path for treating chronic gut disorders. Grid Innovation: New Jersey is developing PowerUp NJ, a program that would pay residents and businesses to use smart devices, batteries and EV chargers to help ease peak electricity demand.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
